Cita APA

Van Driessche, A., Berneman, Z. N., & Van Tendeloo, V. F. I. (2012). Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients with Hematological Malignancies and Solid Tumors: Lessons from Early Clinical Trials. AlphaMed Press.

Citación estilo Chicago

Van Driessche, Ann, Zwi N. Berneman, y Viggo F. I. Van Tendeloo. Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients With Hematological Malignancies and Solid Tumors: Lessons From Early Clinical Trials. AlphaMed Press, 2012.

Cita MLA

Van Driessche, Ann, Zwi N. Berneman, y Viggo F. I. Van Tendeloo. Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients With Hematological Malignancies and Solid Tumors: Lessons From Early Clinical Trials. AlphaMed Press, 2012.